2025年12月70%普通股基上涨 诺安研究精选涨幅居前

Group 1 - In December 2025, among 1,054 comparable ordinary equity funds, 754 funds saw performance increases, representing over 70% of the total [1] - The top-performing funds included Baoying National Security Hong Kong-Shenzhen Stock A and C, and Nuon Research Selected Stock A and C, all of which increased by over 20% [1] - Baoying National Security Hong Kong-Shenzhen Stock, managed by Rong Zhineng, achieved a return of 80% in less than three years [1] Group 2 - The top ten holdings of Baoying National Security Hong Kong-Shenzhen Stock include leading semiconductor companies such as Huahong Semiconductor and SMIC, contributing to its strong performance [1] - Nuon Research Selected Stock's top ten holdings include companies in aerospace, nuclear fusion, and semiconductors, also showing significant gains in 2025 [2] - The fund is managed by Tang Chen, who has been with Nuon Fund since 2019 and became the fund manager in December 2022 [2] Group 3 - The pharmaceutical sector was the main contributor to declines in December 2025, with Baoying Medical Health Hong Kong-Shenzhen Stock A and C dropping by 13.26% and 13.20% respectively [3] - The top ten holdings of Baoying Medical Health include companies like Innovent Biologics and Hengrui Medicine, which experienced significant declines in the market [3] - Other funds that saw notable declines included Nord Strategy Return A and C, with losses of 12.12% and 12.09% respectively [3]